Waxler Regulatory Consultancy believes that the petitioner’s proposed FDA actions (Section I) will minimize iatrogenic injuries from LASIK, thus leading to less morbidity and to better utilization of health care dollars.
IV. Environmental Impact
VI. Certification
Enter search terms or a module, class or function name.